Main Industry
Health Care
Main Product/Service
Market information collection and market analysis for the biotechnology and medical industry, featuring three major services: "Bioinformatics Integrated Analysis," "Genetic Testing Platform Integration Services," and "Medical Testing Component Integration Services."
The content above was translated by Ai
Founded Year
2020
Unified Business No.
83588646
Status
Active
Number of Employees
1
Total Paid-in
Capital
10,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Website
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
成發生技股份有限公司 (Prosperity Biotech Inc.) is a startup company founded in 2020 (the 109th year of the Republic of China) by Mr. Ming-Da Chen, a director of TG Alliance Biotech Co., Ltd. In its early stages of establishment, the company focused primarily on market information collection and market analysis for the biotechnology and medical industries. After conducting research and investigation into the biotechnology industry and ICT medical-related application fields, Cheng-Fa Biotech decided to venture into the field of biotechnology precision medicine, and is expected to increase its capital to 18 million NTD in 2023 (the 112th year of the Republic of China) to invest sufficient funds into emerging biotechnology fields, including digital healthcare, biomedical information integration, and biomedical technology investment management.
The content above was translated by Ai
